-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Amgen, Raises Price Target to $362

Benzinga·08/05/2026 17:54:11
语音播报
Truist Securities analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $340 to $362.